Back
Johnson & Johnson Vs. AbbVie Industry Stock Comparison
Sell
24
JNJ
Johnson & Johnson
Last Price:
148.54
Seasonality Move:
2.69%
Sell
50
ABBV
AbbVie
Last Price:
167.89
Seasonality Move:
2.71%
Sell
24
Johnson & Johnson (JNJ)
is a Sell
Is Johnson & Johnson a Buy, Sell or Hold?
- The current Johnson & Johnson [JNJ] share price is $148.53. The Score for JNJ is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- JNJ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $167.80. The Score for ABBV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $148.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JNJ is experiencing buying pressure, which is a positive indicator for future bullish movement.
ABBV Stock Price Chart
JNJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.46 | Sell |
| Relative Strength Index (14 RSI): | 39.59 | Sell |
| Chaikin Money Flow: | 5454657 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (147.6 - 156.12) | Sell |
| Bollinger Bands (100): | (152.73 - 161.03) | Sell |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.56 | Sell |
| Relative Strength Index (14 RSI): | 44.01 | Sell |
| Chaikin Money Flow: | -419205 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (165.16 - 178.24) | Sell |
| Bollinger Bands (100): | (156.67 - 177.81) | Buy |
JNJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 147.21 | Buy |
| 20-day SMA: | 150.94 | Sell |
| 50-day SMA: | 155.64 | Sell |
| 200-day SMA: | 158.31 | Sell |
| 8-day EMA: | 148.36 | Buy |
| 20-day EMA: | 150.39 | Sell |
| 50-day EMA: | 153.79 | Sell |
| 200-day EMA: | 157.64 | Sell |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 165.6 | Buy |
| 20-day SMA: | 170.13 | Sell |
| 50-day SMA: | 174.9 | Sell |
| 200-day SMA: | 156.53 | Buy |
| 8-day EMA: | 167.19 | Buy |
| 20-day EMA: | 169.35 | Sell |
| 50-day EMA: | 170.94 | Sell |
| 200-day EMA: | 160.67 | Buy |
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.15 per share, an increase this year of $0.73 per share, and an increase next year of $0.33 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.19 per share, an increase this year of $0.03 per share, and an increase next year of $0.96 per share.
Johnson & Johnson Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||